7 biopharma trends to watch in 2019


The industry’s year ahead will be shaped by trends impacting biopharma’s perception, investment and future growth. Criticism and scrutiny from lawmakers will likely remain, scientific advances in oncology, cell and gene therapy should continue to expand, and digital opportunities could spur further executive changes. Here are seven trends to watch in 2019:


  1. Political pressure on drugmakers rises
  2. Price hikes remain but companies become more selective
  3. Oncology remains a top draw for biopharma
  4. FDA keeps pace of approvals high — presuming shutdown doesn’t linger
  5. Rise of the pharma chief digital officer
  6. Biosimilars begin to bite in the U.S.
  7. Ecosystem supporting cell and gene therapy grows


Read the full article at biopharmadive.com…


Comments are closed.

Read previous post:
FDA staff return to work, but threat of second shutdown looms

FDA staff returned to paid work on Monday after the longest government shutdown in US history. However, with funding set...